Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pepsinogen B pseudogene refers to a gene duplication of pepsinogen B (Pgb), an aspartic protease zymogen involved in gastric digestion, that has become non-functional due to frameshift mutations, premature stop codons, or other disabling changes[1][4][5]. Unlike its protein-coding counterparts, the pseudogene does not produce a functional protein and plays no direct enzymatic or signaling role in physiology or disease. Although pseudogenes can sometimes act as regulatory RNAs, no evidence suggests such a function for the PGBP locus. For most research and therapeutic purposes, pepsinogen B pseudogene is not considered a valid drug target, receptor, or biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pepsinogen B pseudogene.